Blog
    Peptide SpotlightFor PatientsJune 25, 2026

    Larazotide Acetate: Can it help with leaky gut?

    Learn how Larazotide Acetate works to stabilize gut tight junctions and why clinical trials for celiac disease have shown inconsistent results.

    What exactly is this stuff?

    Larazotide Acetate is what we call an oral octapeptide. In plain English, that just means it is a tiny protein you swallow. Unlike most medications that travel through your blood to your whole body, this one is nonsystemic. That is a fancy way of saying it stays right in your gut and does not show up in your bloodstream at all.

    How is it supposed to work?

    Think of your intestinal lining like a gate. When you have certain digestive issues, that gate gets a bit loose, which scientists call paracellular permeability. You might have heard people call this leaky gut, though researchers prefer the term tight junction regulation.

    Larazotide Acetate is designed to act like a piece of tape for those gates. Specifically, it tries to:

    • Stabilize tight junctions, which are the seals between the cells in your gut.
    • Keep the barrier working, so things stay where they belong.
    • Stop certain immune cells from piling up, specifically those triggered by gliadin, which is a part of gluten.

    Does it actually do anything?

    This is where things get a little complicated. Scientists have mostly studied it in people with celiac disease who are already eating a gluten-free diet but still have symptoms.

    In some Phase II studies (middle-stage human trials), people taking a low dose of 0.5 mg three times a day reported feeling better. However, when researchers looked at the actual tissue or used tests to measure how well the gut barrier was working, the results were inconsistent. It seems to help with how people feel, but it hasn't consistently proven it can actually fix the physical damage or normalize the gut barrier.

    Why isn't it at the pharmacy yet?

    If you are looking for this at your local drug store, you won't find it. It is currently an investigational drug, meaning it is not FDA-approved.

    A major study called CeDLara was recently stopped in June 2022. Why? Because the results at the halfway point showed it wasn't performing significantly better than a placebo (a sugar pill).

    Scientists are still scratching their heads over a few things:

    • The dose response is weird. Usually, more medicine means a stronger effect, but this peptide does not follow that logical path.
    • The evidence is thin for general use. While people talk about it for leaky gut, there is zero evidence provided to support using it for general gut repair outside of specific clinical studies.

    The bottom line

    Larazotide Acetate is a great example of how hard it is to map out the human body. While it showed promise for helping with symptoms, it has not yet proven it can reliably change the structure of the gut. This is a great one to bring up with your doctor. You can find peptide-experienced physicians in our Find a Doctor directory.


    This content is sourced exclusively from TruthTides clinical reference data and does not constitute medical advice.

    Referenced Peptides

    This content was generated from TruthTides clinical reference data. It does not constitute medical advice. Always consult a qualified healthcare provider.